🔎 Trials Near Me

Akèy › Maladi kadyovaskilè › Kansas

Etid klinik pou Maladi kadyovaskilè nan Kansas

18 etid pou Maladi kadyovaskilè ap chèche patisipan nan sit nan Kansas.

Vil nan Kansas

Tèks ofisyèl etid la (Anglè)

ELEVATE-HFpEF Clinical Study

  • University of Kansas Medical Center, Kansas City
Ap rekrite
Laj 40 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06678841

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  • AMR El Dorado, El Dorado
  • Cotton O'Neil Diabetes & Endocrinology Center, Topeka
  • Tekton Research - Wichita, Wichita
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07064473

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

  • Midwest Heart and Vascular Specialists, Overland Park
  • Kansas Nephrology Physicians, PA, Wichita
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06909565

Product Surveillance Registry

  • Kansas City
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Sep 18, 2026 · NCT01524276

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

  • Clinical Trial Site, Hutchinson
  • Clinical Trial Site, Kansas City
  • Clinical Trial Site, Topeka
  • ak 2 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT07181109

Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.

  • University of Kansas Medical Center, Kansas City
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT03242642

Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

  • The University Of Kansas Medical Center, Kansas City
Ap rekrite
Laj 18 a 100 · Tout sèks · Mizajou Sep 9, 2026 · NCT06310031

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

  • University of Kansas Hospital, Kansas City
  • Cotton O Neil Clinical Res Center, Topeka
Ap rekriteFaz 3
Laj 18 a 100 · Tout sèks · Mizajou Sep 4, 2026 · NCT07517263

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

  • Clinical Research Site, Kansas City
Ap rekriteFaz 2
Laj 18 a 85 · Tout sèks · Mizajou Sep 2, 2026 · NCT07333183

Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults

  • University of Kansas Medical Center, Kansas City
  • VA Eastern Kansas Healthcare System, Topeka
Ap rekriteFaz 4Volontè an sante akeyi
Laj 75 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT04262206

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

  • Research Site, Kansas City
  • Research Site, Kansas City
  • Research Site, Topeka
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT07000357

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

  • Hutchinson Clinic PA, Hutchinson
  • University of Kansas Medical Center, Kansas City
  • Midwest Heart and Vascular Specialists, Overland Park
Ap rekriteFaz 3
Laj 50 a 105 · Tout sèks · Mizajou Aug 21, 2026 · NCT07136012

Global Paradise System US Post Approval Study

  • Ascension via Christi St. Francis, Wichita
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 12, 2026 · NCT06297291

The Oxford Risk Factors And Non-Invasive Imaging Study

  • Midwest Heart & Vascular Specialists LLC, Kansas City
  • St Luke's Hospital, Kansas City
Ap rekriteEtid obsèvasyon
Laj 18 a 99 · Tout sèks · Mizajou Jul 31, 2026 · NCT05169333

PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

  • University of Kansas Medical Center (KUMC), Kansas City
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 29, 2026 · NCT05934487

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

  • Kansas University Medical Center, Kansas City
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 10, 2026 · NCT06526195

Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial

  • Midwest Heart and Vascular Specialists, Overland Park
Ap rekriteFaz 3
Laj 35 a 80 · Tout sèks · Mizajou Apr 16, 2026 · NCT07293260

Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)

  • University of Kansas Medical Center, Kansas City
Ap rekriteFaz 1/2
Laj 35 a 65 · Tout sèks · Mizajou Jun 8, 2025 · NCT04715022

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.